IDNA vs. MDEV
Compare and contrast key facts about iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and First Trust Indxx Medical Devices ETF (MDEV).
IDNA and MDEV are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IDNA is a passively managed fund by iShares that tracks the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. It was launched on Jun 11, 2019. MDEV is a passively managed fund by First Trust that tracks the performance of the Indxx Global Medical Equipment Index. It was launched on Jun 22, 2021. Both IDNA and MDEV are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
IDNA vs. MDEV - Performance Comparison
Loading graphics...
IDNA vs. MDEV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 10.92% | 17.26% | -0.72% | -7.63% | -42.28% | -10.15% |
MDEV First Trust Indxx Medical Devices ETF | -9.41% | 2.00% | 1.79% | 7.55% | -28.59% | 4.16% |
Returns By Period
In the year-to-date period, IDNA achieves a 10.92% return, which is significantly higher than MDEV's -9.41% return.
IDNA
- 1D
- 4.46%
- 1M
- -6.68%
- YTD
- 10.92%
- 6M
- 23.74%
- 1Y
- 43.65%
- 3Y*
- 8.86%
- 5Y*
- -8.02%
- 10Y*
- —
MDEV
- 1D
- 2.23%
- 1M
- -9.05%
- YTD
- -9.41%
- 6M
- -4.81%
- 1Y
- -5.71%
- 3Y*
- -2.27%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IDNA vs. MDEV - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is lower than MDEV's 0.70% expense ratio.
Return for Risk
IDNA vs. MDEV — Risk / Return Rank
IDNA
MDEV
IDNA vs. MDEV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and First Trust Indxx Medical Devices ETF (MDEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | MDEV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.58 | -0.30 | +1.88 |
Sortino ratioReturn per unit of downside risk | 2.21 | -0.31 | +2.52 |
Omega ratioGain probability vs. loss probability | 1.26 | 0.96 | +0.30 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | -0.37 | +3.57 |
Martin ratioReturn relative to average drawdown | 10.48 | -1.17 | +11.66 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IDNA | MDEV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.58 | -0.30 | +1.88 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.28 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | -0.31 | +0.41 |
Correlation
The correlation between IDNA and MDEV is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
IDNA vs. MDEV - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.06%, while MDEV has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.06% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
MDEV First Trust Indxx Medical Devices ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
IDNA vs. MDEV - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than MDEV's maximum drawdown of -42.34%. Use the drawdown chart below to compare losses from any high point for IDNA and MDEV.
Loading graphics...
Drawdown Indicators
| IDNA | MDEV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -42.34% | -25.92% |
Max Drawdown (1Y)Largest decline over 1 year | -12.11% | -14.88% | +2.77% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | — | — |
Current DrawdownCurrent decline from peak | -45.31% | -32.20% | -13.11% |
Average DrawdownAverage peak-to-trough decline | -36.04% | -25.39% | -10.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.83% | 4.66% | -0.83% |
Volatility
IDNA vs. MDEV - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 10.11% compared to First Trust Indxx Medical Devices ETF (MDEV) at 5.67%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than MDEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IDNA | MDEV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.11% | 5.67% | +4.44% |
Volatility (6M)Calculated over the trailing 6-month period | 18.36% | 10.88% | +7.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.87% | 18.99% | +8.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.53% | 19.00% | +9.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.69% | 19.00% | +10.69% |